AN2 Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
AN2 Therapeutics, Inc.‘s stocks are currently a part of 21 hedge funds’ portfolios, which represents 7.18% of the total amount of its stocks outstanding. This makes up a total of 1.10M shares of AN2 Therapeutics, Inc.. Compared to the previous quarter, the number fell by -88.72% or -8.66M shares fewer. As for the holding position changes, 57.14% (12) of current hedge fund investors increased the number of shares held, 19.05% (4) of current holders sold a part of the shares held, and 9.52% (2) closed the holdings completely. 2 hedge funds are new holders of AN2 Therapeutics, Inc. stock in Q1 2023, it is 9.52% of total holders.
Hedge funds holding AN2 Therapeutics (Q1 2016 – Q1 2023)
| Q1 2016 | 57 |
|---|---|
| Q2 2016 | 60 |
| Q3 2016 | 59 |
| Q4 2016 | 52 |
| Q1 2017 | 50 |
| Q2 2017 | 54 |
| Q3 2017 | 60 |
| Q4 2017 | 68 |
| Q1 2018 | 57 |
| Q2 2018 | 1 |
| Q3 2018 | 0 |
| Q1 2019 | 1 |
| Q2 2019 | 0 |
| Q1 2022 | 18 |
| Q2 2022 | 34 |
| Q3 2022 | 35 |
| Q4 2022 | 36 |
| Q1 2023 | 21 |
Hedge funds changes in AN2 Therapeutics positions (Q1 2016 – Q1 2023)
| Q1 2016 | 10 | 26 | 13 | 9 | -1 |
|---|---|---|---|---|---|
| Q2 2016 | 13 | 21 | 16 | 8 | 2 |
| Q3 2016 | 9 | 21 | 18 | 9 | 2 |
| Q4 2016 | 9 | 16 | 24 | 15 | -12 |
| Q1 2017 | 8 | 14 | 21 | 6 | 1 |
| Q2 2017 | 9 | 16 | 19 | 5 | 5 |
| Q3 2017 | 11 | 15 | 22 | 5 | 7 |
| Q4 2017 | 17 | 21 | 18 | 9 | 3 |
| Q1 2018 | 3 | 16 | 26 | 14 | -2 |
| Q2 2018 | 0 | 0 | 0 | 56 | -55 |
| Q3 2018 | 0 | 0 | 0 | 1 | -1 |
| Q1 2019 | 1 | 0 | 0 | 0 | 0 |
| Q2 2019 | 0 | 0 | 0 | 1 | -1 |
| Q1 2022 | 18 | 0 | 0 | 0 | 0 |
| Q2 2022 | 21 | 6 | 4 | 5 | -2 |
| Q3 2022 | 3 | 14 | 11 | 2 | 5 |
| Q4 2022 | 6 | 22 | 3 | 5 | 0 |
| Q1 2023 | 2 | 12 | 4 | 2 | 1 |